RxDoctor Payments Data

Nathan Lebwohl, MD

Orthopaedic Surgery of the Spine · Miami, FLNPI 1649234220

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $46,975 of the $47,909 with a category attached, or 98.0%. Premia Spine, Ltd. accounts for 98.0% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2021 at $38,575 and has fallen 99.6% since, to $147 in 2024.

$47,909in general payments, 2019–2025

Across 21 payments — averaging $2281.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Premia Spine, Ltd.$47K
  • Stryker$460
  • Innovation Technologies Inc$199
  • Icotec Medical Inc.$147
  • Depuy Synthes Products, Inc.$128
$34,238in research payments, 2019–2025

Across 17 payments — averaging $2014.02 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$31K
  • Carbofix Spine Inc$3K

What the payments were for

  • Royalty or licence$1280%
  • Consulting fees$46,97598%
  • Food & beverage$8062%

General payments by program year

19
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$47,909 in reported general payments places this provider in the 60th percentile of 159 orthopaedic surgery of the spine providers in Florida.

See all orthopaedic surgery of the spine providers in Florida

Medicare billing

Part B allowed, 2024
$13,749
Medicare patients
85
Services billed
117

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin26$345

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →